News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BOESS CARSTEN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/17/2022 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 22,000 options to buy
@ $12.03, valued at
$264.7k
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $26.09, valued at
$391.4k
|
|
| 08/10/2020 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 08/03/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/18/2020 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $19.9, valued at
$398k
|
|
| 06/11/2020 |
3
| BOESS CARSTEN (Director) has filed a Form 3 on Avidity Biosciences, Inc. |
| 01/30/2019 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $14.56, valued at
$436.8k
|
|
| 05/29/2018 |
4
| BOESS CARSTEN (10% Owner) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Converted 6,392 shares
@ $0
Bought 6,392 options to buy
@ $15.6438, valued at
$100k
Converted 107,050 options to buy
@ $0
Converted 6,392 options to buy
@ $0 |
|
| 05/23/2018 |
3
| BOESS CARSTEN (10% Owner) has filed a Form 3 on Kiniksa Pharmaceuticals, Ltd. |
| 04/02/2018 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $18.75, valued at
$750k
|
|
| 06/21/2017 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP|
Txns:
| Granted 45,000 options to buy
@ $1.8, valued at
$81k
|
|
| 06/27/2016 |
4
| BOESS CARSTEN (Director) has filed a Form 4 on INOTEK PHARMACEUTICALS CORP|
Txns:
| Granted 12,000 options to buy
@ $7.61, valued at
$91.3k
|
|
| 01/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/23/2015 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Disposed/sold 24,000 shares
@ $0
Disposed/sold 9,929 options to buy
@ $1.7, valued at
$16.9k
Disposed/sold 7,292 options to buy
@ $23, valued at
$167.7k
Disposed/sold 45,000 options to buy
@ $40.32, valued at
$1.8M
Disposed/sold 15,938 options to buy
@ $40.74, valued at
$649.3k
Disposed/sold 40,000 options to buy
@ $80.35, valued at
$3.2M
|
|
| 06/09/2015 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 24,000 shares
@ $0 |
|
| 02/19/2015 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 8,989 shares
@ $98.85, valued at
$888.6k
Sold 14,750 shares
@ $99.97, valued at
$1.5M
Sold 16,716 shares
@ $100.74, valued at
$1.7M
Sold 1,842 shares
@ $101.69, valued at
$187.3k
Exercised 13,235 options to buy
@ $1.7, valued at
$22.5k
Exercised 29,062 options to buy
@ $40.74, valued at
$1.2M
|
|
| 10/30/2014 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 1,500 shares
@ $80, valued at
$120k
Sold 1,000 shares
@ $80, valued at
$80k
Sold 22,904 shares
@ $80.11, valued at
$1.8M
Exercised 1,500 options to buy
@ $1.7, valued at
$2.6k
Exercised 1,000 options to buy
@ $23, valued at
$23k
Exercised 15,050 options to buy
@ $1.7, valued at
$25.6k
Exercised 7,854 options to buy
@ $23, valued at
$180.6k
|
|
| 06/05/2014 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 40,000 options to buy
@ $80.35, valued at
$3.2M
|
|
| 05/20/2014 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 8,136 shares
@ $81.75, valued at
$665.1k
Sold 1,591 shares
@ $82.71, valued at
$131.6k
Sold 200 shares
@ $83.46, valued at
$16.7k
Exercised 9,927 options to buy
@ $1.7, valued at
$16.9k
|
|
| 02/20/2014 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 1,000 shares
@ $100.07, valued at
$100.1k
Sold 3,081 shares
@ $101.14, valued at
$311.6k
Sold 3,207 shares
@ $102.18, valued at
$327.7k
Sold 1,745 shares
@ $103.05, valued at
$179.8k
Sold 894 shares
@ $104.22, valued at
$93.2k
Exercised 9,927 options to buy
@ $1.7, valued at
$16.9k
|
|
| 11/20/2013 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 3,861 shares
@ $53.98, valued at
$208.4k
Sold 1,765 shares
@ $54.97, valued at
$97k
Sold 3,801 shares
@ $55.99, valued at
$212.8k
Sold 500 shares
@ $57.2, valued at
$28.6k
Exercised 9,927 options to buy
@ $1.7, valued at
$16.9k
|
|
| 08/22/2013 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 7,800 shares
@ $47.04, valued at
$366.9k
Sold 6,681 shares
@ $47.19, valued at
$315.3k
Exercised 5,627 options to buy
@ $1.7, valued at
$9.6k
Exercised 2,173 options to buy
@ $23, valued at
$50k
Exercised 6,681 options to buy
@ $23, valued at
$153.7k
|
|
| 08/20/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/15/2013 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 13,237 shares
@ $47.06, valued at
$622.9k
Exercised 13,237 options to buy
@ $1.7, valued at
$22.5k
|
|
| 06/10/2013 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 45,000 options to buy
@ $40.32, valued at
$1.8M
|
|
| 10/18/2012 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 7,127 shares
@ $49.88, valued at
$355.5k
Sold 1,900 shares
@ $50.58, valued at
$96.1k
Sold 900 shares
@ $51.17, valued at
$46.1k
Exercised 9,927 options to buy
@ $1.7, valued at
$16.9k
|
|
| 07/20/2012 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 6,618 shares
@ $48.82, valued at
$323.1k
Exercised 6,618 options to buy
@ $1.7, valued at
$11.3k
|
|
| 06/29/2012 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 45,000 options to buy
@ $40.74, valued at
$1.8M
|
|
| 05/18/2012 |
4
| BOESS CARSTEN (SVP, CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Sold 28,137 shares
@ $38.16, valued at
$1.1M
Sold 11,572 shares
@ $38.82, valued at
$449.2k
Exercised 39,709 options to buy
@ $1.7, valued at
$67.5k
|
|
| 01/11/2012 |
4/A
| BOESS CARSTEN (CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 25,000 options to buy
@ $23, valued at
$575k
|
|
| 12/22/2011 |
4
| BOESS CARSTEN (CFO) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 25,000 options to buy
@ $23, valued at
$575k
|
|
| 11/10/2011 |
3
| BOESS CARSTEN (CFO) has filed a Form 3 on SYNAGEVA BIOPHARMA CORP |
|
|
|